Cargando…

Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor

Three different antibodies against a human TNF receptor (htr-1, htr-5, and htr-9) have been examined for their binding pattern to U937 cells and ability to mimic TNF-alpha activity in U937 cells, Fs4 fibroblasts, and human endothelial cells. Flow cytometric analysis revealed that htr- 5 and htr-9 bo...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1990
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187730/ https://www.ncbi.nlm.nih.gov/pubmed/1689365

Ejemplares similares

Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors
Publicado: (1990)

Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha
por: Liao, Xinmei, et al.
Publicado: (2021)

Development of monoclonal antibodies for quantification of bovine tumor necrosis factor-α
por: Sipka, Anja, et al.
Publicado: (2021)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

Development of specific monoclonal antibodies for the detection of natural chicken tumor necrosis factor-alpha
por: Yang, Yi, et al.
Publicado: (2022)

Systemic administration of an anti-tumor necrosis factor-alpha monoclonal antibody protects against endotoxin-induced uveitis in rats
por: Ge, Qingman, et al.
Publicado: (2016)

Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1
Publicado: (1986)

Characterization of the binding properties and retrograde axonal transport of a monoclonal antibody directed against the rat nerve growth factor receptor
Publicado: (1985)

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
por: Ceran, Ceyhan, et al.
Publicado: (2012)

Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
por: Kim, Ji Woong, et al.
Publicado: (2022)

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation
por: Kirkham, Bruce W, et al.
Publicado: (2014)

Generation and Characterization of Novel Diagnostic Mouse Monoclonal Antibodies Against Human Estrogen Receptor Alpha and Progesterone Receptor
por: Hassanzadeh Makoui, Masoud, et al.
Publicado: (2022)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
por: Gulli, Salvatore, et al.
Publicado: (2003)

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
Publicado: (1989)

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
por: Rowlinson-Busza, G., et al.
Publicado: (1995)

Production and Characterization of Monoclonal Antibodies against Human Prostate Specific Antigen
por: Bayat, Ali Ahmad, et al.
Publicado: (2015)

Production and Characterization of a Murine Monoclonal Antibody Against Human Ferritin
por: Bayat, Ali Ahmad, et al.
Publicado: (2013)

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX
por: Lenferink, Anne E.G., et al.
Publicado: (2021)

Characterization of Plasminogen Binding to NB4 Promyelocytic Cells Using Monoclonal Antibodies against Receptor-Induced Binding Sites in Cell-Bound Plasminogen
por: Jardí, Mercè, et al.
Publicado: (2012)

In vitro characterization of AA71, a potent and selective human monoclonal antibody against CGRP receptor
por: Shi, L, et al.
Publicado: (2013)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors
Publicado: (1979)

Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus monoclonal antibody
por: Kouno, Michiyoshi, et al.
Publicado: (2013)

Establishment and Characterization of Monoclonal Antibodies Against SARS Coronavirus
por: Ohnishi, Kazuo
Publicado: (2007)

Characterization of Monoclonal Antibodies against Human Leukocyte Common Antigen (CD45)
por: Shin, Hyang-Mi, et al.
Publicado: (2011)

Development and Characterization of New Monoclonal Antibodies against Human Recombinant CA XII
por: Dekaminaviciute, Dovile, et al.
Publicado: (2014)

Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis
por: Fujimori, Takeshi, et al.
Publicado: (2023)

Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A
por: Zheng, Songmao, et al.
Publicado: (2020)

Production of Monoclonal Antibody against Human Nestin
por: Hadavi, Reza, et al.
Publicado: (2010)

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse(®)
por: Coughlin, Melissa, et al.
Publicado: (2007)

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75
Publicado: (1995)

Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort
por: Khoury, Gisèle, et al.
Publicado: (2020)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model
por: Takasago, Takeshi, et al.
Publicado: (2023)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
por: Ben-Aissa, H., et al.
Publicado: (1985)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
por: Lang, Isabell, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cudr20gmd04n1p4iog6qhsdofs